Corcept Therapeutics (CORT) total liabilities

Total liabilities · fiscal 2025
$188.85M

Corcept Therapeutics (CORT) had total liabilities of $188.85M at the end of fiscal 2025 (December 31, 2025). That is 17.3% higher than the $160.96M of fiscal 2024. Figures as of 19 Nov 2026, 02:23 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$188.85M
Change on fiscal 2024
+17.3%
Growth, 5 years
+31.3% a year
Highest on record
$188.85Mfiscal 2025
Lowest on record
$29.57Mfiscal 2017
Fiscal years on record
92017–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Corcept Therapeutics total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 31.3% a year. Across the 9 fiscal years on record (2017–2025), the highest was $188.85M in fiscal 2025 and the lowest $29.57M in fiscal 2017.

History · 9 fiscal years

Total liabilities by fiscal year

Corcept Therapeutics total liabilities, year by year

Corcept Therapeutics (CORT) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$188.85M 17.3% up
2024$160.96M 40.2% up
2023$114.81M 40.7% up
2022$81.59M 70.2% up
2021$47.95M 0.9% down
2020$48.39M 17.7% up
2019$41.13M 14.8% up
2018$35.81M 21.1% up
2017$29.57M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

More on CORT

Corcept Therapeutics, figure by figure

Corcept Therapeutics (CORT) overview: price, valuation and scorecardAll health care companies by market value

Corcept Therapeutics total liabilities: questions and answers

How large are Corcept Therapeutics's total liabilities?

Corcept Therapeutics (CORT) had total liabilities of $188.85M at the end of fiscal 2025 (December 31, 2025). That is 17.3% higher than the $160.96M of fiscal 2024.

What is the growth rate of Corcept Therapeutics's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 31.3% a year.

What are the highest and lowest total liabilities figures on record for Corcept Therapeutics?

Across the 9 fiscal years on record (2017–2025), the highest was $188.85M in fiscal 2025 and the lowest $29.57M in fiscal 2017.

How is Corcept Therapeutics's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Corcept Therapeutics it is on record here for 9 fiscal years, 2017 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Corcept Therapeutics (CORT) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/CORT/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.